---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-040823"
form_type: "8-K"
ticker: "COO"
cik: "0000711404"
company_name: "COOPER COMPANIES, INC."
filed_at: "2026-06-04T20:27:28+00:00"
generated_at: "2026-06-04T20:59:38.066060+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# CooperCompanies Q2 revenue $1.082B (+8% YoY); non-GAAP EPS $1.21 (+26%); records $271.6M litigation charge

## Summary
- Revenue $1.082B (+8% reported, +5% organic); CooperVision $723.5M (+8%), CooperSurgical $358.0M (+8%).
- GAAP diluted EPS of $(0.40) due to $271.6M net litigation charge; non-GAAP diluted EPS $1.21, up 26% YoY.
- Recorded $271.6M net charge ($324.1M liabilities less $52.5M insurance) for CooperSurgical fertility media recall; settled >95% of over 1,500 claimants.
- Fiscal 2026 guidance: revenue $4.285-$4.321B; non-GAAP diluted EPS $4.58-$4.66; reaffirms long-term free cash flow target >$2.2B for FY26-28.
- Repurchased $13.1M in common stock (174k shares) at avg $75.84; $860.8M remaining under buyback authorization.

## SEC filing metadata
- accession: 0001628280-26-040823
- form_type: 8-K
- ticker: COO
- cik: 0000711404
- company_name: COOPER COMPANIES, INC.
- filed_at: 2026-06-04T20:27:28+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/0001628280-26-040823-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/coo-20260604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-040823
- JSON: https://secwatch.observer/filing/0001628280-26-040823.json
- Plain text: https://secwatch.observer/filing/0001628280-26-040823.txt

## Key facts
- Earnings Releases
  COOPER COMPANIES, INC. reported fiscal year 2026 results: revenue $4.285 - $4.321 billion, EPS $4.58 - $4.66.
  - Period: fiscal year 2026
  - Revenue: $4.285 - $4.321 billion
  - EPS: $4.58 - $4.66
  - Result: guidance update
  source text: The Company updated its fiscal year 2026 financial guidance. Details are summarized as follows: • Fiscal 2026 total revenue of $4.285 - $4.321 billion (organic growth of 3.5% to 4.5%) • CVI revenue of $2.883 - $2.908 billion (organic growth of 3.5% to 4.5%) • CSI revenue of $1.402 - $1.414 billion (organic growth of 4% to 5%) • Fiscal 2026 non-GAAP diluted EPS of $4.58 - $4.66 • Reaffirm previously communicated long-term free cash flow objective exceeding $2.2 billion for fiscal years 2026 through 2028
  evidence_url: https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/0001628280-26-040823-index.htm
- Earnings Releases
  COOPER COMPANIES, INC. reported fiscal second quarter ended April 30, 2026 results: revenue $1.082 billion, EPS $(0.40) per diluted share.
  - Period: fiscal second quarter ended April 30, 2026
  - Revenue: $1.082 billion
  - EPS: $(0.40) per diluted share
  - Result: reported results
  source text: • Second quarter 2026 revenue of $1.082 billion, up 8%, or up 5% organically, from last year's second quarter. • Second quarter 2026 GAAP diluted earnings per share (EPS) of $(0.40), down $0.84 from last year's second quarter driven by a litigation-related charge to resolve outstanding claims associated with a December 2023 voluntary product recall at CooperSurgical. • Second quarter 2026 Non-GAAP diluted EPS of $1.21, up $0.25 or 26% from last year's second quarter.
  evidence_url: https://www.sec.gov/Archives/edgar/data/711404/000162828026040823/0001628280-26-040823-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.